Literature DB >> 6869759

Etomidate infusion. Its use in anaesthesia for general surgery.

B Scorgie.   

Abstract

Etomidate has been studied in two groups of patients. In Group 1, 50 patients received etomidate 100 micrograms/kg/minute with fentanyl and a muscle relaxant, ventilation being with air and oxygen (50%). The technique gave a smooth, pleasant induction with all patients asleep within 2 minutes. The incidence of pain on infusion was 6% and of myoclonus 6%. Cardiovascular changes were minimal, the most common finding being persistent tachycardia. The mean recovery time was 9.1 minutes. There was no incidence of awareness, recall, or thrombophlebitis, but a 20% incidence of nausea and vomiting. In Group 2, 20 patients received the same dosage of etomidate to supplement spinal anaesthesia for lower abdominal surgery. The technique worked most satisfactorily, with patients falling quietly to sleep within 2-3 minutes with no hiccoughs, coughing or laryngospasm. Six patients exhibited myoclonus, one being severe. In no case did myoclonus interfere with the operation. The cardiovascular system remained stable in all patients. Mean recovery time was 16.1 minutes (range 3-38 minutes). Twitching and restlessness were the main complications during recovery.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6869759     DOI: 10.1111/j.1365-2044.1983.tb15182.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

Review 1.  Clinical and molecular pharmacology of etomidate.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

2.  Polymorphisms of pharmacogenetic candidate genes affect etomidate anesthesia susceptibility.

Authors:  Lulin Ma; Yan Huang; Shiqian Huang; Feng Xu; Yafeng Wang; Shuai Zhao; Daling Deng; Yuanyuan Ding; Tianhao Zhang; Wenjing Zhao; Xiangdong Chen
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.